Technical Analysis for SNY - Sanofi

Grade Last Price % Change Price Change
grade C 42.28 0.40% 0.17
SNY closed up 0.4 percent on Friday, May 24, 2019, on 1.14 times normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Up
See historical SNY trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
20 DMA Support Bullish 0.00%
Up 3 Days in a Row Strength 0.00%
20 DMA Support Bullish 0.40%
Cup with Handle Other 0.40%
Inside Day Range Contraction 0.40%
Crossed Above 20 DMA Bullish 0.45%
MACD Bullish Signal Line Cross Bullish 0.45%
Narrow Range Bar Range Contraction 2.67%
NR7 Range Contraction 2.67%

Older signals for SNY ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Sanofi researches, develops, manufactures, and markets healthcare products worldwide. The company operates through Pharmaceuticals, Human Vaccines, and Animal Health segments. Its principal products include Lantus and Apidra analogs of human insulin; Insuman, a range of human insulin solutions and suspensions; Amaryl, an oral once-daily sulfonylurea; BGStar and iBGStar blood glucose meters; enzyme replacement therapies, such as Cerezyme for Gaucher disease, Fabrazyme for Fabry, and Myozyme/Lumizyme for Pompe disease; Aubagio, an oral immunomodulator for multiple sclerosis; Taxotere, a taxane derivative for various cancer types; Eloxatine for colorectal cancer; and Jevtana for prostate cancer. The company's products also consist of thrombosis medicines, such as Plavix anti-platelet agent for atherothrombotic conditions and Lovenox to prevent and treat deep vein thrombosis; and cardiovascular medicines include Multaq anti-arrhythmic agent and Aprovel/CoAprovel for hypertension treatments. It also offers Renagel/Renvela oral phosphate binders used in patients with chronic kidney disease on dialysis to treat high phosphorus levels; Synvisc and Synvisc-One viscosupplements to treat pain associated with osteoarthritis of certain joints; and pediatric and influenza, adult and adolescent booster, meningitis and pneumonia, and travel and endemics vaccines. In addition, the company provides pharmaceuticals and vaccines used by veterinarians, farmers, and pet owners; consumer health care products to treat fever, pain, and digestive health areas; and generic medicines. Sanofi distributes its products through its sales force, as well as through physicians, pharmacies, hospitals, distributors, veterinaries, chemists, and wholesalers. It has alliance arrangements with Bristol-Myers Squibb, Regeneron, and Warner Chilcott. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1970 and is headquartered in Paris, France.
Cancer Healthcare Life Sciences Pharmaceutical Industry Pain Pharmaceuticals Prostate Cancer Health Sciences Multiple Sclerosis Influenza Dialysis Chronic Kidney Disease Osteoarthritis Colorectal Cancer Healthcare Products Hypertension Insulin Cac 40 Hepatotoxins Bristol Myers Squibb Sanofi Fever Pneumonia Pompe Disease Thrombosis Consumer Health Care Products Deep Vein Thrombosis Gaucher Disease Enzyme Replacement Therapies Regeneron
Is SNY a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 45.62
52 Week Low 37.67
Average Volume 1,048,309
200-Day Moving Average 43.1874
50-Day Moving Average 42.9276
20-Day Moving Average 42.0885
10-Day Moving Average 41.613
Average True Range 0.6378
ADX 19.52
+DI 31.6823
-DI 28.5018
Chandelier Exit (Long, 3 ATRs ) 41.9166
Chandelier Exit (Short, 3 ATRs ) 42.5695
Upper Bollinger Band 44.0627
Lower Bollinger Band 40.1143
Percent B (%b) 0.55
BandWidth 9.381185
MACD Line -0.2362
MACD Signal Line -0.3512
MACD Histogram 0.115
Fundamentals Value
Market Cap 106.18 Billion
Num Shares 2.51 Billion
EPS 4.31
Price-to-Earnings (P/E) Ratio 9.81
Price-to-Sales 2.74
Price-to-Book 1.72
PEG Ratio 1.86
Dividend 1.64
Dividend Yield 3.88%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 43.33
Resistance 3 (R3) 43.34 43.01 43.16
Resistance 2 (R2) 43.01 42.74 43.00 43.10
Resistance 1 (R1) 42.64 42.57 42.83 42.63 43.04
Pivot Point 42.31 42.31 42.40 42.30 42.31
Support 1 (S1) 41.94 42.04 42.13 41.93 41.52
Support 2 (S2) 41.61 41.87 41.60 41.46
Support 3 (S3) 41.24 41.61 41.41
Support 4 (S4) 41.23